FDA mulls long-term use of nicotine-replacement aids

The FDA may recommend long-term--or even permanent--use of nicotine-based quit-smoking aids, rather than the 12 weeks currently advised. The potential move is backed by anti-tobacco activists and GlaxoSmithKline, the leading marketer of nicotine-replacement therapy in the U.S. Report

Suggested Articles

With U.S. presidential and congressional campaigns in full swing, it’s not just Americans anxiously awaiting the results of the upcoming elections.

Sun Pharma has recalled one lot of its generic metformin after finding high levels of the probable carcinogen NDMA in tested lots.

Six months after WHO declared a pandemic, the list of drugs proven to work against the virus remains short. Now, Fujifilm has added its drug Avigan.